Portfolio Rebalancing Decision

An AI-assisted decision support tool for strategic rebalancing

Governance-Ready Analysis

Rebalancing decisions documented with explicit assumptions, execution roadmaps, and risk profiles. Board-ready in minutes, not weeks.

Multiple Paths, One Decision

Present tactical, gradual, and hybrid approaches with clear tradeoffs. MDs choose based on risk appetite, not analyst recommendation.

Assumption Transparency

Every path lists the market conditions, liquidity scenarios, and operational constraints that must hold. Challenge assumptions before committing.

Why This Matters: AI for Institutional Decision-Making

The Problem: Portfolio drift (allocation deviating from policy targets) requires quarterly governance review and rebalancing decisions. Investment committees spend time on mechanical analysis (which paths are possible? what's the timeline?) rather than strategic judgment (which path aligns with our risk stance?). The bottleneck isn't analysis—it's converting analysis into decision-ready documentation.

Why AI Works Here: Claude can reason about portfolio structure (how to minimize execution risk, account for illiquidity constraints, tranche sales by market conditions). It generates multiple paths with explicit, auditable assumptions—not a single black-box recommendation. The output is governance documentation, not a decision directive.

The Result: Investment leaders get decision-ready analysis with 3+ scenarios, documented assumptions, and execution roadmaps. They focus on judgment (which path fits our strategy?), not math (can we execute in 3 weeks?). AI accelerates governance without replacing decision-making. Claude analyzes. You decide. You own the outcome.

Phase 1 MVP

This is a decision framework demo

This tool demonstrates static scenario analysis. Future versions will use real-time Claude AI to dynamically generate paths, validate assumptions, and explain reasoning.

Portfolio Situation

Large Institutional Endowment • Q3 2026Total AUM: $50.0B
Equities
28.0%
Target: 30.0%
↓ Underweight
$1.0B
Fixed Income
18.0%
Target: 10.0%
↑ Overweight
$4.0B
Real Assets
19.0%
Target: 20.0%
↓ Underweight
$500M
Private Equity
12.0%
Target: 15.0%
↓ Underweight
$1.5B
Cash
23.0%
Target: 25.0%
↓ Underweight
$1.0B

Claude's Analysis

The portfolio has drifted significantly from policy targets, with Fixed Income overweight by 800 basis points ($4B) while key growth assets (Equities, Private Equity) remain underweight. This drift has accumulated due to strong fixed income performance and undeployed PE capital. The current environment presents a tactical opportunity: equity valuations are reasonable (S&P 500 at 18x P/E), yield levels support repositioning (2yr at 4.2%), and PE distributions are tracking at $1.2B per quarter. The board has flagged this drift as requiring governance action within the next quarter.

Decision Paths

Choose your rebalancing approach. Each path has different tradeoffs in timing, risk, and execution complexity.

Methodology & Data

Mock Data Format: This demo uses realistic financial data in a simplified custom JSON schema. In production, this tool integrates with your actual data stack: portfolio management systems (e.g., Canoe), market data providers (e.g., Bloomberg), PE performance data (e.g., MSCI Burgiss), and data warehouses (e.g., Azure SQL, Snowflake) to fetch live portfolio and market data.

Rebalancing Logic: Paths and execution roadmaps are pre-generated for demo reliability, but in the full AI-powered version, Claude generates these dynamically based on your actual portfolio state, market conditions, and governance constraints.

Governance-Focused: All recommendations are designed to produce governance-ready documentation: explicit assumptions, risk profiles, execution timelines, and audit trails. This is not algorithmic trading—it's decision-support augmentation for institutional governance.

Phase 1 MVP: This tool demonstrates decision framework visualization. Claude analyzes. You decide. You own the outcome.

Full AI-powered version with dynamic path generation, real-time assumption testing, and live market data coming soon. See "Phase 1 MVP" notice above for details.